Eur Rev Med Pharmacol Sci 2020; 24 (23): 11991-11991
DOI: 10.26355/eurrev_202012_23980

Long noncoding RNA SOX2OT maintains the stemness of pancreatic cancer cells by regulating DEK via interacting with miR-200a/141

C.-S. Liu, Q. Zhou, Y.-D. Zhang, Y. Fu

Department of Hematology, the First Hospital of Jilin University, Changchun, China.


The article “Long noncoding RNA SOX2OT maintains the stemness of pancreatic cancer cells by regulating DEK via interacting with miR-200a/141, by C.-S. Liu, Q. Zhou, Y.-D. Zhang, Y. Fu, published in Eur Rev Med Pharmacol Sci 2020; 24 (5): 2368-2379–DOI: 10.26355/eurrev_202003_20504–PMID: 32196588” has been withdrawn from the authors stating that “to validate the effect of lncRNA-SOX2OT, we constructed SOX2OT overexpressed cells using lentiviral vector with -IRES2-EGFP to easily visualize the transfection efficiency. Therefore, the stably transfected cells were carrying the green fluorescence. However, during our Flow cytometry assay, we took PC cells (Control) with no fluorescence to standardize our equipment and measured the negative control (NC) and overexpressed-Sox2ot (oe-Sox2ot) according to the manufacturer’s guidance, without removing the disturbance that the green fluorescence caused. This means that, despite having performed the standard assay, the results obtained in Figure 2D were wrong and unscientific”.

The Publisher apologizes for any inconvenience this may cause.

https://www.staging.europeanreview.org/article/20504

Free PDF Download

To cite this article

C.-S. Liu, Q. Zhou, Y.-D. Zhang, Y. Fu
Long noncoding RNA SOX2OT maintains the stemness of pancreatic cancer cells by regulating DEK via interacting with miR-200a/141

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 23
Pages: 11991-11991
DOI: 10.26355/eurrev_202012_23980